newsfilter
← Latest News
GlobeNewswire·

GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Company to Provide Updates on Multiple Phase 2 Clinical Trials for GEO-CM04S1 and Gedeptin® ATLANTA, GA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX),